Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00280943|
Recruitment Status : Completed
First Posted : January 24, 2006
Last Update Posted : October 17, 2007
|Condition or disease||Intervention/treatment||Phase|
|Hip Fractures Osteoporosis||Behavioral: Long-term care facilities in the intervention arm will receive education and feedback audit on performance||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||64 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities Written for FDA Approved Medications for Osteoporosis Treatment.|
|Study Start Date :||January 2005|
|Study Completion Date :||March 2007|
- Number of new prescriptions for FDA-Approved osteoporosis medications.
- Secondary Outcome Measures: Changes in number of bone mineral density test ordered, change in the number of hip protectors issued, change in the number of prescriptions for calcium and vitamin D, changes in the rate of new osteoporotic fractures.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00280943
|United States, North Carolina|
|Duke University Medical Center|
|Durham, North Carolina, United States, 27710|
|Principal Investigator:||Kenneth W Lyles, M.D.||Duke University|
|Principal Investigator:||Cathleen S. Colon-Emeric, MD, MHSc||Duke University|